Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?Can turmeric enhance lipitor's efficacy or side effects?When genetic tenofovir alafenamide be available in us?When did risperdal constas patent expire published article?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for betaseron
Betaseron (interferon beta-1b) is injected subcutaneously every other day, which equals about 3-4 times per week.[1] This schedule targets relapsing forms of multiple sclerosis (MS) by reducing relapse frequency and lesion activity.
The dosing stems from clinical trials showing efficacy with 0.25 mg (8 million international units) administered on alternate days. Daily use isn't approved or recommended due to injection site reactions and flu-like symptoms that improve with this spacing.[2][3]
Most inject Monday, Wednesday, Friday, and one extra day (like Sunday), totaling four doses weekly. Missing a dose means resuming the next scheduled day without doubling up. Refrigeration is required until 30 minutes before use; room temperature stability lasts up to 3 hours.[1]
Frequent injections often cause local skin reactions (redness, pain) in 70-85% of patients, plus flu-like symptoms (fever, chills) after 60% of doses initially. These decrease over time; rotating sites and pre-medication with ibuprofen help.[2]
Other Questions About Betaseron :